UAE approves China's Sinopharm vaccine for children 3-17
The decision followed clinical trials in June involving 900 children in Abu Dhabi, including members of the royal family.
The United Arab Emirates has approved the use of the Chinese-made Sinopharm COVID-19 vaccine for children aged 3-17, the Emirati government said Monday.
“The decision comes after clinical trials and extensive evaluations and is based on the emergency use authorization and local evaluations which are in line with the approved regulations,” tweeted the UAE's National Emergency Crisis and Disaster Management Authority.
